Welcome to the Desert Angels™. We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies. The organization serves as a forum for its over 80 members, who invest individually from their personal funds. Since 2000, Desert Angel members have invested over $41.5 million in more than 99 presenting companies.

Tucson Tech: New radiation treatment for eye disease advances

by Curtis Gunn on June 21st, 2017 at 10:58pm

The medical instrument that Tucson-based startup Salutaris Medical Devices is developing can give you the willies, with a hook designed to be inserted behind the eye.

Despite the high yuck factor, Salutaris’ new method for radiation treatment of wet age-related macular degeneration offers new hope for patients with a major cause of age-related blindness.

Read full article here

Comment

Arizona Commerce Authority Announces Grant Awardees in the Spring 2017 Arizona Innovation Challenge

by Curtis Gunn on June 6th, 2017 at 5:30pm

*Desert Angel Portfolio Companies ClickIPO and Codelucida receive AIC grants*

The Spring 2017 round of the Arizona Innovation Challenge (AIC) has concluded as the Arizona Commerce Authority (ACA) today announced six awardees in its bi-annual business plan competition.
The ACA provides $3 million in grants annually to the most qualified, innovative startups and early-stage companies. Each company receives up to $250,000 in capital to grow their business — advancing innovation and technology commercialization opportunities in Arizona.

Companies located anywhere in the world may apply, so long as they plan to establish operations and commercialize their product or service in Arizona if they are awarded an AIC grant.

Read full article here

Comment

20 MOLECULAR DIAGNOSTICS COMPANIES TO WATCH

by Curtis Gunn on February 8th, 2017 at 6:15pm

The molecular diagnostics market is growing, though projections on how fast and how far vary depending on who is studying the field. Grand View Research in October projected a near-tripling of the market to $17.9 billion in 2024, from $6.45 billion in 2015.

That’s just slightly lower than the $6.54 billion market size estimated for molecular diagnostics last year by MarketsAndMarkets, which foresees the field climbing to $10.12 billion by 2021. A third company, Global Market Insights, sees a slightly smaller market of $10.03 billion by 2023.

Read full article here

Comment

Filed under: Funded Companies, Press

New ASU ed-tech accelerator announces first cohort group

by Curtis Gunn on January 23rd, 2017 at 7:46pm

A new Arizona State University ed-tech accelerator designed to move education technology to market faster has announced the program’s first business cohorts.

The ASU Draper GSV Accelerator allows new ventures to be tested by ASU students and faculty, with the plan to allow the technology to move to market faster.

Read full article here

Comment

Comparing Team Communication Apps: What Do You Get For Free?

by Curtis Gunn on January 13th, 2017 at 5:28pm

Technology has always played a big role in business and managing resources more efficiently. Team communication and messaging is one area in particular where we’ve seen a ton of action lately, with apps such as Slack becoming the ultimate tool for workgroup collaboration.

Read full article here

Comment

Filed under: Funded Companies, Press

Scottsdale tech startup is allowing Sun Devil fans easy way to buy tickets

by Curtis Gunn on November 17th, 2016 at 12:00am

Arizona State University sports fans can now buy game tickets simply by responding to a text message thanks to a new partnership between Sun Devil Athletics and Scottsdale-based ReplyBuy.

ReplyBuy allows fans to buy tickets and merchandise through a text message, and introduced a new artificial intelligence featureto its service in October to make the process even smarter.

Read full article here

Comment

Filed under: Funded Companies, Press

Tucson drug startup drops initial public stock offering

by Curtis Gunn on November 16th, 2016 at 3:27pm

A Tucson-based company developing cancer-prevention drugs has withdrawn its initial public offering of stock.

But Cancer Prevention Pharmaceuticals will keep moving forward with trials of its cancer-prevention drugs with the backing of its pharma industry partners, the company’s CEO said.

Read full article here

Comment

Filed under: Funded Companies, Press

Tucson’s NuvOx wins $300K grant

by Curtis Gunn on November 1st, 2016 at 4:31pm

Tucson-based biotech drug startup NuvOx Pharma has been awarded a grant of nearly $300,000 from the National Cancer Institute to study a targeted contrast agent for breast cancer.

Dr. Evan Unger, a University of Arizona radiology professor and co-founder of NuvOx, is co-principal investigator of the grant along with Dr. Juergen Willmann, professor of radiology and a clinical division chief in the radiology department at Stanford University Medical Center.

Read full article here

Comment

Filed under: Funded Companies, Press

Dow Jones: Arizona venture capital plummets to under $20M

by Curtis Gunn on October 20th, 2016 at 8:29pm

Arizona companies did not capitalize much in the third quarter, according to data from Dow Jones VentureSource.

Companies seeking venture capital brought home checks totaling less than $17 million, compared to $55 million in the second quarter this year and $177 million in Q1 2016.

Read full article here

Comment

Filed under: Funded Companies, Press

New partnership, NIH grant push research forward

by Curtis Gunn on October 3rd, 2016 at 11:28pm

Shelby Kutty, M.D., Ph.D. was recently informed that the project, “Fibrin Targeted Microbubbles and Ultrasound for Treatment of Endocarditis,” has been funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dr. Kutty is co-principal investigator with Evan Unger, M.D., co-founder of NuvOx Pharma. Dr. Unger also is professor of radiology at University of Arizona Health Sciences.

NuvOx will develop microbubbles specifically designed to target fibrin. UNMC will use ultrasound to break the bubbles, and with them, the vegetation, while co-administering an antibiotic and also using ultrasound for live imaging purposes.

Read full article here

Comment

Filed under: Funded Companies, Press